US 7,579,321 B2
	Pharmaceutical compositions including low dosages of desmopressin
Seymour Fein, New Canaan, Conn. (US)
Assigned to Reprise Biopharmaceutics, LLC, New City, N.Y. (US)
Filed on Jul. 15, 2008, as Appl. No. 12/173,074.
Application 11/744615 is a division of application No. 10/706100, filed on Nov. 12, 2003.
Application 12/173074 is a continuation of application No. 11/744615, filed on May 04, 2007, granted, now 7,405,203.
Application 10/706100 is a continuation in part of application No. PCT/US03/14463, filed on May 06, 2003.
Claims priority of application No. 0210397.6 (GB), filed on May 07, 2002.
Prior Publication US 2009/0005432 A1, Jan. 01, 2009
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/08 (2006.01); C07K 7/04 (2006.01)

U.S. Cl. 514—16  [530/326]

21 Claims

1. A method for inducing voiding postponement in a patient while reducing the risk that the patient develops hyponatremia comprising delivering to the bloodstream of the patient an amount of desmopressin no more than about 2 ng/kg by intranasal, transdermal, intradermal, transmucosal, or conjunctival administration, said amount being therapeutically effective to produce an antidiuretic effect lasting for no more than between about 4 and about 6 hours.